I-Retemic (i-oxybutynin): yenzelwe ini nokuthi ungayithatha kanjani

-Delile

• Yenzelwe ini
• Isebenza kanjani
• Ungathatha kanjani
• Imiphumela emibi engaba khona
• Ngubani ongafanele asebenzise

I-Oxybutynin yisidakamizwa esikhonjiswe ekwelapheni ukungasebenzi kahle komchamo nokuqeda izimpawu ezihambisana nobunzima bokuchama, njengoba isenzo saso sinomthelela oqondile emisipheni ebushelelezi yesinye, sandisa amandla aso okugcina. Isithako sayo esisebenzayo yi-oxybutynin hydrochloride, enomthelela we-urinary antispasmodic, futhi yaziwa ngokuthengisa njenge-Retemic.

Lo muthi wenzelwa ukusetshenziswa ngomlomo, futhi uyatholakala njengethebhulethi ngemithamo ka-5 no-10 mg, noma njengesiraphu ngomthamo ongu-1 mg / ml, futhi kufanele uthengwe ngomuthi kadokotela emakhemisi amakhulu. Intengo yeRetemic ivame ukwehluka phakathi kwama-reais angama-25 kuye kwangama-50, okuya ngendawo ethengisa kuyo, ubungako bayo nohlobo lomuthi.

Yenzelwe ini

I-Oxybutynin ikhonjisiwe ezimweni ezilandelayo:

• Ukwelashwa kokungahambi kahle komchamo;
• Kwehle ukuphuthuma kokuchama;
• Ukwelashwa kwesinye se-neurogenic noma okunye ukungasebenzi kahle kwesinye;
• Nciphisa ivolumu yomchamo eyeqile ebusuku;
• I-Nocturia (ukwanda komthamo womchamo ebusuku) kanye nokungazibambi kweziguli ezine-neurogenic bladder (ukungasebenzi kahle kwesinye ngokulahlekelwa ukulawulwa komchamo ngenxa yezinguquko ohlelweni lwezinzwa);
• Usizo ekwelapheni izimpawu ze-cystitis noma i-prostatitis;
• Yehlisa izimpawu zokuchama futhi zemvelaphi yengqondo futhi ilusizo ekwelapheni izingane, ezingaphezu kweminyaka emihlanu, ezichama embhedeni ebusuku, lapho kukhonjiswa ngudokotela wezingane. Qonda izimbangela nokuthi kunini lapho kudingeka ukwelashwa ingane emanzisa umbhede.

Ngaphezu kwalokho, njengomunye wemiphumela emibi yesenzo sikaRetemic ukwehla kokukhiqizwa kwezithukuthuku, lo muthi ungakhonjiswa ngenkathi welashwa abantu abane-hyperhidrosis, njengoba ingasebenza ukunciphisa lokhu kungakhululeki.

Isebenza kanjani

I-Oxybutynin inomphumela wokuchama we-antispasmodic, njengoba isebenza ngokuvimba isenzo ohlelweni lwezinzwa lwe-neurotransmitter ebizwa nge-acetylcholine, okuholela ekuphumuleni kwemisipha yesinye, ukuvimbela iziqephu zokucindezelwa okungazelelwe nokulahleka komchamo ngokungenhloso.

Ngokuvamile, ukuqala kwesenzo somuthi kuthatha phakathi kwemizuzu engama-30 kuye kwengu-60 ngemuva kokusetshenziswa, futhi umphumela wawo uvame ukuhlala phakathi kwamahora ayisithupha kuya kwayishumi.

Ungathatha kanjani

Ukusetshenziswa kwe-oxybutynin kwenziwa ngomlomo, ngendlela yethebhulethi noma isiraphu, ngokulandelayo:

Abantu abadala

• 5 mg, 2 noma kathathu ngosuku. Umkhawulo womthamo wabantu abadala ungama-20 mg ngosuku.
• 10 mg, ngesimo sethebhulethi ekhishwa isikhathi eside, izikhathi ezi-1 noma ezi-2 ngosuku.

Izingane ezineminyaka engaphezu kwengu-5 ubudala

• 5 mg kabili ngosuku. Umkhawulo wedosi walezi zingane ngu-15 mg ngosuku.

Imiphumela emibi engaba khona

Eminye yemiphumela emibi engabangelwa ukusetshenziswa kwe-oxybutynin ukozela, isiyezi, umlomo owomile, ukukhiqizwa komjuluko okunciphile, ikhanda elibuhlungu, ukungaboni kahle, ukuqunjelwa, isicanucanu.

Ngubani ongafanele asebenzise

I-Oxybutynin iyaphikiswa ezimweni zabantu abanezinto ezingezwani nomzimba kumthetho osebenzayo noma ezingxenyeni zefomula yayo, i-glaucoma evaliwe, ukuvimba okuncane noma okuphelele kwethambo lamathumbu, amathumbu akhubazekile, i-megacolon, i-megacolon enobuthi, i-colitis enamandla ne-myasthenia enamandla.

Akufanele futhi isetshenziswe ngabesifazane abakhulelwe, abesifazane abancelisayo nezingane ezingaphansi kweminyaka emihlanu ubudala.